[HTML][HTML] Nutraceuticals as therapeutic agents for atherosclerosis

JWE Moss, JO Williams, DP Ramji - … Acta (BBA)-Molecular Basis of Disease, 2018 - Elsevier
Atherosclerosis, a chronic inflammatory disorder of medium and large arteries and an
underlying cause of cardiovascular disease (CVD), is responsible for a third of all global …

Nutraceutical therapies for atherosclerosis

JWE Moss, DP Ramji - Nature Reviews Cardiology, 2016 - nature.com
Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries and is
considered to be a major underlying cause of cardiovascular disease (CVD). Although the …

Nutraceuticals and atherosclerosis: human trials

L Badimon, G Vilahur, T Padro - Cardiovascular therapeutics, 2010 - Wiley Online Library
The high prevalence of obesity, atherosclerosis, and cardiovascular disease (CVD) is
largely attributable to the contemporary lifestyle that is often sedentary and includes a diet …

Nutraceuticals and prevention of atherosclerosis: focus on ω‐3 polyunsaturated fatty acids and mediterranean diet polyphenols

M Massaro, E Scoditti, MA Carluccio… - Cardiovascular …, 2010 - Wiley Online Library
Nutraceuticals are potentially healthful foods that play a role in maintaining human well
being, enhancing health and preventing, or even treating, specific diseases. More than for …

Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes

PE Penson, M Banach - Atherosclerosis, 2021 - Elsevier
Atherosclerosis, a chronic progressive inflammatory condition characterized by the formation
of lipid-laden lesions in arterial walls, is associated with substantial morbidity (including …

Dietary polyphenols for atherosclerosis: A comprehensive review and future perspectives

R Bahramsoltani, F Ebrahimi, MH Farzaei… - Critical reviews in …, 2019 - Taylor & Francis
Atherosclerosis is one of the most prevalent reasons for premature death in adults. Despite
the several conventional drugs in the market; many patients are not completely treated. Here …

Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians

V Habauzit, C Morand - Therapeutic advances in chronic …, 2012 - journals.sagepub.com
Growing evidence suggests that polyphenols could be serious candidates to explain the
protective effects of plant-derived foods and beverages. Based on current studies, a general …

Nutraceuticals and dyslipidaemia: beyond the common therapeutics

P Scicchitano, M Cameli, M Maiello, PA Modesti… - Journal of functional …, 2014 - Elsevier
Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins
represent the evidence-based treatment of choice for reducing low-density lipoprotein …

Cholesterol-lowering nutraceuticals affecting vascular function and cardiovascular disease risk

V Bianconi, MR Mannarino, A Sahebkar… - Current Cardiology …, 2018 - Springer
Abstract Purpose of Review The aim of this review is to provide an update on the effects of
the dietary supplementation with cholesterol-lowering nutraceuticals and nutraceutical …

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

AFG Cicero, F Fogacci, A Colletti - Food & function, 2017 - pubs.rsc.org
Cardiovascular diseases (CVDs) are one of the major causes of mortality and disability in
Western countries. Prevention is known to be the cornerstone to lessen the incidence of …